AIDS News and Research

RSS

Papua New Guinea government stepping down as Global Fund grant principal recipient

Following an audit last year by the Global Fund to Fight AIDS, Tuberculosis and Malaria that found Papua New Guinea's National Department of Health (NDOH) "had not complied with grant guidelines and some $7 million had been misdirected," the government is stepping down as the principal recipient (PR) of Global Fund grants in order to "improve its response," IRIN reports.

20 Jul 2011

Janssen presents EDURANT 96-week Phase 3 trial data at International AIDS Society Conference

Janssen Therapeutics, Division of Janssen Products, LP, presented today 96-week findings from two pivotal Phase 3 clinical trials, known as ECHO and THRIVE, comparing the efficacy, safety and virology profile of its non-nucleoside reverse transcriptase inhibitor EDURANT tablets versus efavirenz (EFV) in antiretroviral treatment-naive, HIV-1-infected adults.

20 Jul 2011

UNC receives $3M federal grant for AIDS research

Scientists at the University of North Carolina at Chapel Hill schools of medicine and pharmacy have been awarded a $3 million federal grant to develop and test a new generation of treatments aimed at preventing sexual transmission of HIV to uninfected individuals.

19 Jul 2011

First comprehensive European patient education programme for women with HIV

"SHE" - Strong, HIV Positive, Empowered Women - the first comprehensive European patient education programme to address the growing challenges faced by women living with HIV, was launched at the 6th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention in Rome, Italy.

19 Jul 2011

DNDi's new drug development programme for children with HIV/AIDS

Today at the 6th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention, the Drugs for Neglected Diseases initiative (DNDi) announced the launch of a new drug development programme to address critical unmet treatment needs of children with HIV/AIDS.

19 Jul 2011

UNAIDS' Sidibe calls for increased access to HIV drugs at IAS conference opening

UNAIDS Executive Director Michel Sidibe on Sunday at the opening of the 6th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention in Rome "called ... for an increase in access to drugs that help treat or prevent the spread of the disease, saying it is 'morally wrong' to keep millions of people off lifesaving medication," the Associated Press/Boston Globe reports.

19 Jul 2011

Scientists discover cholesterol moves far slower within and between cells

Neutrons have shown the movement of cholesterol between and within cells takes far longer than previously thought. Findings could impact the treatment of a range of diseases linked to abnormal rates of cholesterol transfer.

19 Jul 2011

HIV vaccine discovery requires 'open mind'

In response to Washington Post columnist Michael Gerson's July 5 piece in which he highlighted several scientific "breakthroughs" in the search for an AIDS vaccine, Robert Gallo, director of the Institute of Human Virology at the University of Maryland School of Medicine, writes in a Post letter to the editor, "Although Mr. Gerson correctly noted that these discoveries are unrelated, he misperceived their relative significance."

19 Jul 2011

Novel approach for preventing HIV infection

Scientists at Osel Inc. and the National Cancer Institute (NCI) have developed a new way to prevent HIV infection by genetically enhancing the ability of naturally occurring vaginal bacteria to block viral transmission.

19 Jul 2011

Emory-led consortium receives NIH grant to develop effective HIV/AIDS vaccine

A consortium of leading vaccine researchers at Emory University and partner institutions has received a National Institutes of Health (NIH) grant aimed at developing an effective HIV/AIDS vaccine.

19 Jul 2011

BMC receives $1.1 million MDPH grant to expand HIV clinic

The Massachusetts Department of Public Health (MDPH) has awarded a nearly $1.1 million grant to Boston Medical Center (BMC) to provide funding for HIV/AIDS support and case management services.

19 Jul 2011

Viewpoints: NYT on Medicaid's value; WSJ against exchanges; Chicago Tribune on food deserts

Medicaid is under assault these days from nearly every direction. Governors complain that they cannot afford to put up their share of the money. Congressional Republicans led by Paul Ryan want to reduce the federal contribution by $771 billion over the next decade. ... President Obama has expressed willingness to cut Washington's contribution.

19 Jul 2011

Partners of Bacterial Vaginosis sufferers at increased risk of HIV

Starpharma Holdings Limited today commented on results of a study which showed that men were three times more likely to contract HIV from their female partners if the women also had bacterial vaginosis (BV) in the three months before the men became infected.

18 Jul 2011

Rome Statement for an HIV Cure calls for accelerated research

Members of the Advisory Board for a Global Scientific Strategy "Towards an HIV Cure" today launched the Rome Statement for an HIV Cure calling for an acceleration of HIV cure research. The announcement was made at the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) currently being held in Rome

18 Jul 2011

Partners can help advance global HIV/AIDS fight

In a post on the State Department's "DipNote" blog, Ambassador Eric Goosby, the U.S. global AIDS coordinator, highlights recent findings that help reduce the risk of HIV transmission. He writes, "In order for us to fulfill the promise of these findings, we will continue to foster shared responsibility among all parties.

18 Jul 2011

Researchers closer to developing meningitis B vaccine

"New research may bring scientists one step closer to developing a vaccine that protects against hundreds of strains of meningococcus B, the most common cause of bacterial meningitis," according to research published last week in Science Translational Medicine, HealthDay News reports.

18 Jul 2011

ISENTRESS demonstrates comparable efficacy to efavirenz in treatment-naïve adult HIV-1 patients

Merck, known as MSD outside the United States and Canada, today announced final results from a Phase II clinical study, extending out to 240 weeks, of its integrase inhibitor ISENTRESS® (raltegravir) Tablets in combination therapy in previously untreated (treatment-naïve) adult HIV-1-infected patients.

18 Jul 2011

SEEK HIV-v vaccine demonstrates 90% reduction in HIV viral load

SEEK, a privately owned biopharmaceutical company specializing in immunology, announces today that it has completed a Phase Ib/II clinical trial of its HIV-v vaccine which demonstrates a one log (approx 90 percent) difference in viral count in HIV-infected people compared with the placebo group, after just a single vaccine injection.

18 Jul 2011

Experimental online tool launched to guide HIV treatment decisions without the need for resistance testing

A new free online service with the potential to help HIV treatment in countries with limited healthcare resources was launched today. The system accurately predicts how patients will respond to different combinations of drugs without the need for expensive tests to read the viral genetic code. Data presented today at the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) demonstrated the accuracy of the system for patients in Romania and South Africa whose treatment was failing (abstract MOPE146).

18 Jul 2011

Study recommends short and simple HIV consent forms

An in-depth review of consent forms provided to volunteers for HIV/AIDS research in the United States and abroad about study procedures, risks and benefits has found that the forms were extremely long and used wording that may have been complex enough to hinder full understanding, according to bioethicists at The Johns Hopkins University.

16 Jul 2011